Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 501-506

  Taki, Junichi ^a,b   Sumiya, Hisashi ^a   Tsuchiya, Hiroyuki ^a   Tomita, Katsuro ^a   Nonomura, Akitaka ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

bone tumor; chemotherapy; soft tissue tumor; technetium 99m MIBI; thallium 201

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BONE TUMOR; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SCHOOL CHILD; SOFT TISSUE TUMOR;

ABSCESS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DISEASES; BONE NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE ANGIOGRAPHY; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES;

EID: 0030899247     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hisada K. Tonami N, Miyamae T, el al. Clinical evaluation of lumor imaging with thallium-20l chloride. Radiology 1978;129:497-500.
2. Ancri D, Basset JY, Lonchampt MF. Etavard C. Diagnosis of cerebral lesions by thallium-201. Radiology 1978;128:417-422.
3. Tonami N. Shuke N, Yokoyama K, et al. Thallium-201 single-photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
4. Charkes ND, Vitti RA, Brooks K. Thallium-201 SPECT increases detectabilit/ of thyroid cancer métastases. J Nucl Med 1990:31:147-153.
5. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993:34:18-23.
6. Howman-Giles R, Uren RF, Shaw Pi. Thallium-201 scintigraphy in pédiatrie joMtissue tumors. J Nucl Med 1995:36:1372-1376.
7. McCall D, Zimmer LS, Katz AM. Kinetics of thallium exchange in cultured rat myocardial cells. Circ Res 1985:56:370-376.
8. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m-MIBI imaging in patients with malignant tumors. Preliminary results and comparison with TI-201. Clin Nucl Med 1992:17:171-176.
9. Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m seslariibi and TI-201 in unsuspected breast tumor. Clin Nucl Med 1992:17:936-937.
10. O'Tuama LA, Trêves ST, Larar JN, et al. Thallium-201 versus technetium-99m-M!Bl SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993:34:1045-1051.
11. Balon HR, Fink BD, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992:33:1393-1395.
12. Bom HS, Kim JY, Kim YC, Choi IS, Park KO. Technetium-99m-MIBl uptake in simultaneous thyroid and lung cancers. Clin Nucl Med 1994:19:604-606.
13. Scott AM, Kostakoglu L, O'Brien JP. et al. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J. Nucl Med 1992:33: 1396-1398.
14. Desai SP, Yuille DL. Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 1993:34:1748-1751.
15. Maublant JC, Zhang Z, Rapp M, et al. In vitro uptake of technetium-99m-teboroxi ne in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993:34:1949-1952.
16. Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemothe-apeutic response. J Nucl Med 1990:31:567-572.
17. Caner B. Kitapcl M, Unlu M, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med 1992:33:319-24.
18. Carvalho PA, Chiu ME, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MlBI in isolated perfused rat hearts. J Nucl Med 1992:33:1516 -1522.
19. Piwnica WD, Kronauge JF, Chiu ME. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondria! a id plasma membrane potential dependence. Circulation 1990:82:1826-1838.
20. Beanlands RS, Dawood F, Wen WH, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990:82:1802-1814.
21. Delmon-Moigeeon El, Piwnica-Worms D. Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990:50:2198-2202.
22. Maublant JC, Zhang Z, Rapp M, Oilier M, Michelot J, Veyre A. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison wi'h technetium-99m-sestamibi and thallium-201. J Nucl Med 1993:34:1949-1952.
23. Piwnica-Worms D, Chiu ME, Budding M, Kronauge JE, Kramer RA, Croop JM. Functional imaging of multidrug-resistant p-glycoprotein with an organotechnetium complex. Cancer Res 1993:53:977-984.
24. Rao VV, Chiu-ME, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumtlation of technetium-99m-sestamibi. J Nucl Med 1994:35:510-515.
25. Cordobes MD, Starzec A, Delmon-Moingeon E, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.J Nucl Med 1996:37:286-289.
26. Sehweil AM, McKillop JH, Milroy R, Wilson R. Abdel-Daycm HM, Omar Y1. Mechanism of 201T1 uptake in tumors. Eur J Nucl Med 1989:15:376-379.
27. Caluser C, Macapinlac H, Healey J, et al. The relationship between thallium uptake, blood flow, and blood-pool activity in bone and soft-tissue tumors. Clin Nucl Me,I 1992:17:565-572.